Results 151 to 160 of about 23,271,535 (305)

Publisher Correction: The bandgap-detuned excitation regime in photonic-crystal resonators

Nature Communications
Yan Jin, Erwan Lucas, Jizhao Zang, Travis Briles, Ivan Dickson, David Carlson, Scott B. Papp   +6 more
doaj   +1 more source

Aligning cardiac monitoring with American Heart Association Guidelines: Impact on utilization, hemodynamic monitoring, and outcomes. [PDF]

PLoS One
Hilliard B, Mehta T, Grace J, Pestka DL, Ingraham NE, Beebe T, Tignanelli C, Melton GB, Shippee N, Koopmeiners JS, Usher M.   +10 more
europepmc   +1 more source

In vitro properties of patient serum predict clinical outcome after high dose rate brachytherapy of hepatocellular carcinoma

Molecular Oncology, EarlyView.
Following high dose rate brachytherapy (HDR‐BT) for hepatocellular carcinoma (HCC), patients were classified as responders and nonresponders. Post‐therapy serum induced increased BrdU incorporation and Cyclin E expression of Huh7 and HepG2 cells in nonresponders, but decreased levels in responders.
Lukas Salvermoser, Jan Niklas Schäfer, Shraga Nahum Goldberg, Philipp Maximilian Kazmierczak, Moritz Nikolaus Gröper, Philipp Franz Linden, Elif Öcal, Tanja Burkard, Stefanie Corradini, Najib Ben Khaled, Moritz Wildgruber, Max Seidensticker, Jens Ricke, Matthias Stechele, Marianna Alunni‐Fabbroni   +14 more
wiley   +1 more source

Quantification of eef1a1l1 transcript in early zebrafish development. [PDF]

MicroPubl Biol
Ligunas GD, Materna SC.
europepmc   +1 more source

STANDARD TIME

Monthly Weather Review, 1907
openaire   +1 more source

Inhibition of CDK9 enhances AML cell death induced by combined venetoclax and azacitidine

Molecular Oncology, EarlyView.
The CDK9 inhibitor AZD4573 downregulates c‐MYC and MCL‐1 to induce death of cytarabine (AraC)‐resistant AML cells. This enhances VEN + AZA‐induced cell death significantly more than any combination of two of the three drugs in AraC‐resistant AML cells.
Shuangshuang Wu, Jianlei Zhao, Aaban Asfar Azmi, Avanti Gupte, Jenna Thibodeau, Shuang Liu, Jinli Yang, Guan Wang, Holly Edwards, Lisa A. Polin, Juiwanna Kushner, Sijana H. Dzinic, Kathryn White, Julie Boerner, Maik Hüttemann, Jay Yang, Yue Wang, Jeffrey W. Taub, Yubin Ge   +18 more
wiley   +1 more source

Which medical subspecialties use qualitative research? A bibliometric analysis. [PDF]

BMJ Open
Gittus M, Sutton A, Lagojda L, O'Cathain A, Fotheringham J.   +4 more
europepmc   +1 more source

A synthetic benzoxazine dimer derivative targets c‐Myc to inhibit colorectal cancer progression

Molecular Oncology, EarlyView.
Benzoxazine dimer derivatives bind to the bHLH‐LZ region of c‐Myc, disrupting c‐Myc/MAX complexes, which are evaluated from SAR analysis. This increases ubiquitination and reduces cellular c‐Myc. Impairing DNA repair mechanisms is shown through proteomic analysis.
Nicharat Sriratanasak, Bodee Nutho, Worawat Wattanathana, Narumon Phaonakrop, Bunnatut Panasawatwong, Katharina Erlenbach‐Wuensch, Sittiruk Roytrakul, Regine Schneider‐Stock, Pithi Chanvorachote   +8 more
wiley   +1 more source

Challenges in performing clinical research on herbal products - experiences from Switzerland and the UK. [PDF]

Front Pharmacol
Bourqui A, Csajka C, Heinrich M, Podmore C, Simpson C, Trill J, Willcox M, Rodondi PY.   +7 more
europepmc   +1 more source